Days at Home After Serious Health Events Among Community‐Living Older Persons
Journal of the American Geriatrics Society · 2026-05 · 74 (5) · 1265-1273
DOI: 10.1111/jgs.70376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 10.03.2026. Verfasst von Thomas M Gill und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, Department of Internal Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Critical Illness. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Yale Claude D. Pepper Older Americans Independence Center, National Institute on Aging.
Abstract (Originalsprache)
Background
Days spent at home have been identified as a clinically meaningful patient‐centered outcome, especially in older persons. Serious health events in this population have pronounced deleterious effects on functional well‐being. Our objective was to determine whether and how days spent at home differ in the 6 months after specific types of serious health events.
Methods
From a prospective longitudinal study of 754 community‐living persons, aged 70 years or older, we calculated the number of days at home as 180 minus the number of overnight days in a health care facility and days not alive. The occurrence of serious health events, including critical illness, major surgery (non‐elective and elective), and other hospitalizations, were ascertained primarily through linkages with Medicare data.
Results
Days at home were diminished in the 180 days after each type of serious health event. Relative to a reference group, the adjusted rate ratios (95% CI), representing the mean number of days at home as a proportion, were 0.70 (0.64–0.77) for critical illness, 0.70 (0.64–0.76) for non‐elective major surgery, 0.87 (0.84–0.91) for elective major surgery, and 0.86 (0.83–0.89) for other hospitalization. The corresponding absolute reductions (95% CI) in mean days at home were 48.6 (37.9–59.3), 50.1 (39.7–60.5), 20.7 (14.3–27.0), and 22.9 (17.9–28.0), respectively. Of the time not spent at home, days in a nursing facility were most common except for critical illness, which had the highest mortality; days in a hospice facility were least common; and days in a hospital differed relatively little across the groups.
Conclusion
Days spent at home are considerably diminished after serious health events. These findings may help guide older persons, their families, and physicians about what to expect after hospital discharge for different types of serious health events, and they suggest potential strategies that may optimize time spent at home.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale School of Medicine, Department of Internal Medicine, New Haven, Connecticut, USA.
- Yale School of Medicine, Department of Surgery, New Haven, Connecticut, USA.
ORCID-Profile: Thomas M Gill, Lauren E Ferrante
Förderung
- NIA NIH HHS
- Yale Claude D. Pepper Older Americans Independence Center
- National Institute on Aging
Zitieren
APA
Gill, T. M., Leo-Summers, L., Gahbauer, E. A., Becher, R. D., Ferrante, L. E., & Han, L. (2026). Days at Home After Serious Health Events Among Community‐Living Older Persons. Journal of the American Geriatrics Society, 74(5), 1265-1273. https://doi.org/10.1111/jgs.70376
Vancouver
Gill TM, Leo-Summers L, Gahbauer EA, Becher RD, Ferrante LE, Han L. Days at Home After Serious Health Events Among Community‐Living Older Persons. Journal of the American Geriatrics Society. 2026;74(5):1265-1273. doi:10.1111/jgs.70376
BibTeX
@article{Gill2026,
author = {Gill, Thomas M and Leo-Summers, Linda and Gahbauer, Evelyne A and Becher, Robert D and Ferrante, Lauren E and Han, Ling},
title = {Days at Home After Serious Health Events Among Community‐Living Older Persons},
journal = {Journal of the American Geriatrics Society},
year = {2026},
volume = {74},
number = {5},
pages = {1265--1273},
doi = {10.1111/jgs.70376}
}
EUVIMED